The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Comparison of pharmacodynamic properties of various estrogen formulations
Abstract
A group of 23 healthy postmenopausal women received one or more 2-week courses of daily administration of the following estrogen preparations: piperazine estrone sulfate (Ogen), 0.3, 0.625, 1.25, 2.5, and 5.0 mg; micronized estradiol (Estrace), 1, 2, and 10 mg; conjugated estrogens (Premarin), 0.3, 0.625, 1.25, and 2.5 mg; ethinyl estradiol (Estinyl), 10 and 20 micrograms; and diethylstilbestrol, 0.1 and 0.5 mg. Each dosage of each formulation was ingested by three women. In those women who received more than one dosage, each course was separated by a drug-free interval of at least 4 weeks. Pretreatment and posttreatment levels of follicle-stimulating hormone (FSH), luteinizing hormone (LH), corticosteroid-binding globulin-binding capacity, sex hormone-binding globulin-binding capacity, angiotensinogen, estrone, and estradiol were determined. The relative potency of these five estrogen formulations was determined by parallel line analysis for each of these responses, except LH. On a weight basis, piperazine estrone sulfate and micronized estradiol were equipotent for all responses. Conjugated estrogens suppressed FSH in a fashion equipotent to that of the other nonsynthetic estrogens; however, for all three hepatic parameters, the response was exaggerated twofold to threefold. The synthetic estrogens, diethylstilbestrol and ethinyl estradiol, were relatively more potent on a weight basis for every response and produced the most marked response (fourfold to eighteenfold in excess of their FSH suppression) for the hepatic parameters.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It is a potent estrogen having up to 600 times greater effect on hepatic protein synthesis than natural estradiol (E2)”
From Ethinylestradiol in combined hormonal contraceptive has a broader effect on serum proteome compared with estradiol valerate: a randomized controlled trial (2023) · cites this paper as Mashchak et al., 1982
In the citing paper
“In the liver, COCs stimulate the synthesis of steroid-binding globulins, such as sex hormone-binding globulin (SHBG), thereby affecting circulating, free steroid levels”
From Ethinylestradiol in combined hormonal contraceptive has a broader effect on serum proteome compared with estradiol valerate: a randomized controlled trial (2023) · cites this paper as Mashchak et al., 1982
In the citing paper
“EE increases SHBG, CBG and angiotensinogen multifold compared with estradiol (Mashchak et al., 1982).”
From Ethinylestradiol in combined hormonal contraceptive has a broader effect on serum proteome compared with estradiol valerate: a randomized controlled trial (2023) · cites this paper as Mashchak et al., 1982
Citations
Cites
ANDERSON, D. C. (1974) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1974.tb03298.x · Cited by 1,127
Book Review: International Encyclopedia of Pharmacology and Therapeutics
Paton, W. D. M. (1967) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591576706000438 · Cited by 312
Serum gonadotropin and steroid patterns during the normal menstrual cycle
Mishell, D. R., Nakamura, R. M., Crosignani, P. G., Stone, S. C., Kharma, K. M., Nagata, Y., & Thorneycroft, I. H. (1971) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(71)90927-6 · Cited by 264
Self-citationEggena, P., Barrett, J. D., Sambhi, M. P., & Wiedeman, C. E. (1974) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-39-5-865 · Cited by 71
Self-citationAn in vivo system in man for quantitation of estrogenicity
Moore, D. E., Kawagoe, S., Davajan, V., Mishell, D. R., & Nakamura, R. M. (1978) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(78)90293-4 · Cited by 64
Self-citationAn in vivo system in man for quantitation of estrogenicity
Moore, D. E., Kawagoe, S., Davajan, V., Nakamura, R. M., & Mishell, D. R. (1978) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(78)90294-6 · Cited by 57
Self-citationEffect of Several Estrogens on Serum Gonadotropin Levels in Postmenopausal Women
Franchimont, P., Legros, J. J., & Meurice, J. (2009) · Hormone and Metabolic Research · doi:10.1055/s-0028-1094069 · Cited by 29
Quantitative relationships of the pituitary-gonadal axis in postmenopausal women.
Aj, W., Gross, M. A., & Ds, S. (1973) · PubMed · Cited by 25
USE OF A POST-MENOPAUSAL SERUM POOL AS A REFERENCE PREPARATION FOR RIA OF GONADOTROPHINS
Nakamura, R. M., Nagata, Y., Osborn, C., & Mishell, D. R. (1974) · European Journal of Endocrinology · doi:10.1530/acta.0.0750478 · Cited by 12
Self-citationIsaacs, A., & Havard, C. W. H. (1978) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1978.tb02214.x · Cited by 5
Research works printed but not linked: 1
- Delaunois, 1972, vol. 2, 988
Cited by
Sorted by citations
Items 201–300 of 317
Effect of estrogen on exercise electrocardiograms in healthy postmenopausal women
Rovang, K. S., Arouni, A. J., Mohiuddin, S. M., Tejani, A. M., & Hilleman, D. E. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)00974-7 · Cited by 12
Patching up a better pill for GH-deficient women
Birzniece, V., & Ho, K. K. Y. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.9 · Cited by 12
The pill, HRT and postoperative thromboembolism: cause for concern?
Whitehead, E. M., & Whitehead, M. I. (1991) · Anaesthesia · doi:10.1111/j.1365-2044.1991.tb09646.x · Cited by 12
Toward a new concept of “natural balance” in oral estroprogestin contraception
Chabbert‐Buffet, N., Gerris, J., Jamin, C., Lello, S., Lete, I., Lobo, P., Nappi, R. E., & Pintiaux, A. (2013) · Gynecological Endocrinology · doi:10.3109/09513590.2013.824963 · Cited by 11
Current status of estrogen receptors
Ray, S., Rastogi, R., & Kumar, A. (2002) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8171-5_7 · Cited by 11
Sturdee, D. W. (1997) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1997.tb10932.x · Cited by 11
Hormone replacement therapy for the postmenopausal woman
Christiansen, C. (2001) · Maturitas · doi:10.1016/s0378-5122(01)00198-0 · Cited by 11
Tassi, A., Londero, A. P., Xholli, A., Lanzolla, G., Bertozzi, S., Savelli, L., Prefumo, F., & Cagnacci, A. (2025) · Pharmaceuticals · doi:10.3390/ph18010061 · Cited by 10
Raudaskoski, T., Laatikainen, T., & Kauppila, A. (1998) · Maturitas · doi:10.1016/s0378-5122(98)00003-6 · Cited by 10
Stegeman, B. H., Vos, H. L., Helmerhorst, F. M., Rosendaal, F. R., Reitsma, P. H., & Vlieg, A. V. H. (2017) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2017.05.019 · Cited by 12
Cieraad, D., Conradt, C., Jesinger, D. K., & Bakowski, M. T. (2006) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-006-0132-4 · Cited by 10
Løbo, R. A. (2007) · Elsevier eBooks · doi:10.1016/b978-0-323-02951-3.50045-5 · Cited by 10
Metabolic and endocrine effects of the desogestrel-containing oral contraceptive Mircette™
Berga, S. L. (1998) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(98)70291-1 · Cited by 10
Stanczyk, F. Z., Yang, J. L., Bennink, H. J. T. C., Sriprasert, I., Winer, S. A., Foidart, J., & Archer, D. F. (2025) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000002547 · Cited by 9
Tailoring Combination Oral Contraceptives to the Individual Woman
Archer, D. F., & Lasa, I. L. (2011) · Journal of Women s Health · doi:10.1089/jwh.2010.2199 · Cited by 9
Morbid obesity: potential effects of hormonal contraception
Stanczyk, F. Z., Burke, A. E., Hong, K. M., & Archer, D. F. (2018) · Contraception · doi:10.1016/j.contraception.2018.05.008 · Cited by 9
Lee, S. R., Jeong, S. H., Heo, J. H., Jo, S. L., Ko, J., Kwun, H., & Hong, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212557 · Cited by 9
Metabolic effect of two hormonal preparations in postmenopausal women
Bissonnette, F., Lussier‐Cacan, S., Fugère, P., & Bérubé, S. (1997) · Maturitas · doi:10.1016/s0378-5122(97)00042-x · Cited by 9
Chapter 3. Impact of estrogens on hemostasis
Stanczyk, F. Z., Sriprasert, I., Chulapongwanich, S., Yang, J. L., & Fruzzetti, F. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1617731 · Cited by 9
Sex Hormones and Vascular Function
Bowling, M. R., Oparil, S., Hage, F. G., Hilgers, R. H. P., & Xing, D. (2012) · InTech eBooks · doi:10.5772/38940 · Cited by 8
Fintini, D., Alba, M., & Salvatori, R. (2005) · Experimental Biology and Medicine · doi:10.1177/153537020523001004 · Cited by 8
Rosen, H. N., Parker, R. A., Greenspan, S. L., Iloputaife, I., Bookman, L., Chapin, D., Perlmutter, I., Kessel, B., Qvist, P., & Rosenblatt, M. (2004) · Calcified Tissue International · doi:10.1007/s00223-003-0114-5 · Cited by 8
Miller, V. T., & LaRosa, J. C. (1991) · Springer eBooks · doi:10.1007/978-1-4612-3014-4_5 · Cited by 8
Ellerington, M. C., & Stevenson, J. C. (1992) · Drugs & Aging · doi:10.2165/00002512-199202060-00006 · Cited by 8
Long-Term Follow-Up and Treatment of a Female With Complete Estrogen Insensitivity
Brakta, S., Chorich, L. P., Kim, H., Coons, L. A., Katzenellenbogen, J. A., Hall, J. E., Korach, K. S., & Layman, L. C. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa106 · Cited by 7
Filho, R. V. D. O., Antunes, N. D. J., Ilha, J. O., Moreno, R. A., Wedemeyer, R., Warnke, A., & Nucci, G. D. (2018) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13822 · Cited by 7
Dull, P. (2006) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2006.09.008 · Cited by 7
Low thrombin generation in postmenopausal women using estetrol
Morimont, L., Didembourg, M., Bouvy, C., Jost, M., Taziaux, M., Oligschlaeger, Y., van Rooijen, M. A., Gaspard, U., Foidart, J., & Douxfils, J. (2024) · Climacteric · doi:10.1080/13697137.2023.2292066 · Cited by 6
Løbo, R. A. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4907-4.00014-0 · Cited by 6
SHULMAN, L. P. (2013) · Journal of Family Planning and Reproductive Health Care · doi:10.1136/jfprhc-2013-100605 · Cited by 6
An update on new orally administered contraceptives for women
Nelson, A. L. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.1100173 · Cited by 5
Løbo, R. A. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-2758-2.00015-9 · Cited by 5
Isotton, A. L., Wender, M. C. O., & Czepielewski, M. A. (2008) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302008000500023 · Cited by 5
Pouillès, J. M., Gosset, A., & Trémollières, F. (2021) · Gynécologie Obstétrique Fertilité & Sénologie · doi:10.1016/j.gofs.2021.03.015 · Cited by 18
Pharmacokinetics of Contraceptive Steroids in Humans
Goebelsmann, U. (1986) · Springer eBooks · doi:10.1007/978-1-4613-2241-2_4 · Cited by 5
Osteoporosis: Prevention and Management
Riffee, J. M. (1992) · American Pharmacy · doi:10.1016/s0160-3450(15)31036-9 · Cited by 5
Le traitement hormonal de la ménopause en pratique. RPC Les femmes ménopausées du CNGOF et du GEMVi
Gosset, A., Robin, G., Letombe, B., Pouillès, J. M., & Trémollières, F. (2021) · Gynécologie Obstétrique Fertilité & Sénologie · doi:10.1016/j.gofs.2021.03.019 · Cited by 4
Managing Menopause by Combining Evidence With Clinical Judgment
Flores, V. A., & Pal, L. (2018) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000384 · Cited by 4
Abdalla, K. A., Shabaan, M. M., & Stanczyk, F. Z. (1992) · Contraception · doi:10.1016/0010-7824(92)90045-u · Cited by 4
Secretion Effect of Estrogen of Different Growth Stages of Silkworm (Bombyx mori L.)
Ryu, K., Lee, H.-S., Kim, K.-Y., Kim, M., Oh, H.-G., & Kang, P. (2011) · International Journal of Industrial Entomology · doi:10.7852/ijie.2011.22.1.17 · Cited by 4
Menopause and Care of the Mature Woman
Lobo, R. A. (2012) · Elsevier eBooks · doi:10.1016/b978-0-323-06986-1.00014-7 · Cited by 4
Self-citationA prodrug design for improved oral absorption and reduced hepatic interaction
Ahmed, G., Elger, W. A. G., Meece, F. A., Nair, H. B. B., Schneider, B., Wyrwa, R., & Nickisch, K. J. (2017) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.08.027 · Cited by 4
Human versus non-human sex steroid use in hormone replacement therapies part 1: Preclinical data
Atwood, C., & Ekstein, S. F. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2018.10.003 · Cited by 4
9 Oestrogen therapy and cardiovascular disease: Do the benefits outweigh the risks?
Bush, T. L., & Miller-Bass, K. (1991) · Baillière s Clinical Obstetrics and Gynaecology · doi:10.1016/s0950-3552(05)80295-0 · Cited by 4
The Bioavailability of Desogestrel/Ethinyl Estradiol Tablets Relative to the Oral Solution
Hunt, T. L., Geetha, R., & Warga, E. (1998) · Clinical Drug Investigation · doi:10.2165/00044011-199815060-00007 · Cited by 4
Does the type of progestin influence the production of clotting factors?
Stanczyk, F. Z., Mathews, B. W., & Cortessis, V. K. (2016) · Contraception · doi:10.1016/j.contraception.2016.07.007 · Cited by 3
Novick, A. M., Stoddard, J., Johnson, R. L., Duffy, K. A., Berkowitz, L. N., Costa, V. D., Sammel, M. D., & Epperson, C. N. (2023) · PLoS ONE · doi:10.1371/journal.pone.0279764 · Cited by 4
Fruzzetti, F., Machado, R. B., Lete, I., Patel, A., & Boolell, M. (2024) · European Journal of Obstetrics & Gynecology and Reproductive Biology X · doi:10.1016/j.eurox.2024.100283 · Cited by 3
Advantages and disadvantages of estrogen treatment by transdermal or oral administration
Rozenbaum, H. (1996) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/0028-2243(95)02300-h · Cited by 3
Terapia ormonale sostitutiva in menopausa
Padova, G., Minnella, D. P., & Velardita, V. (2002) · L Endocrinologo · doi:10.1007/bf03344407 · Cited by 3
Løbo, R. A. (2015) · Climacteric · doi:10.3109/13697137.2015.1007428 · Cited by 3
Estrogen regulation of tissue plasminogen activator in a human melanoma cell line
Kjældgaard, A., Larsson, B., & Åstedt, B. (1986) · Thrombosis Research · doi:10.1016/0049-3848(86)90268-9 · Cited by 3
Chabbert‐Buffet, N., Guigues, B., Trillot, N., Biron, C., Morange, P., Pernod, G., Scheffler, M., Brugere, S., & Hedon, B. (2013) · Journal de gynécologie, obstétrique et biologie de la reproduction. Supplément/Journal de gynécologie obstétrique et biologie de la reproduction · doi:10.1016/j.jgyn.2013.03.015 · Cited by 2
A New Estradiol-Dienogest Oral Contraceptive Marks “The Pill's” 50th Anniversary
Keder, L. M. (2010) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e3182068cc6 · Cited by 2
Complications and Adverse Sequelae of Sclerotherapy
Goldman, M. P. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-37726-3.00008-3 · Cited by 2
Effect of hormone therapy on personality traits: preliminary evidence in older men and women
Schroeder, R. A., Mordecai, K. L., Resnick, S. M., Terracciano, A., Dobs, A. S., Durso, S. C., Costa, P. T., & Maki, P. M. (2024) · Climacteric · doi:10.1080/13697137.2024.2393128 · Cited by 2
Current trends in hormone replacement therapy
Khashoggi, T. Y. (2002) · Saudi Medical Journal · doi:10.15537/1658-3175.1691 · Cited by 2
From Primary Hypergonadotropic Amenorrhea to “POI”: Aetiology and Therapy
Bruni, V., Bucciantini, S., & Ambroggio, S. (2017) · ISGE series · doi:10.1007/978-3-319-41433-1_7 · Cited by 2
Effects Of Estrogen and Progesterone Used in Oral Contraceptive Pills: A review
Noori, F., & Althanoon, Z. A. (2022) · Al-Mağallaẗ al-ʻirāqiyyaẗ li-l-ṣaydalaẗ · doi:10.33899/iphr.2022.0174808 · Cited by 2
Oral oestrogen treatment of the climacteric and the postmenopausal period
Campagnoli, C., Sandri, A., & Belforte, P. (1984) · Springer eBooks · doi:10.1007/978-94-009-5608-7_13 · Cited by 2
Overview: Inhibitors of Bone Resorption and Implications for Therapy
Zaidi, M., Alam, A. T., Shankar, V. S., Fairburn, K., Huang, C. L.-H., Moonga, B. S., Panetta, J., Blake, D. R., & Pazianas, M. (1992) · Current Opinion on Therapeutic Patents · doi:10.1517/13543776.2.10.1517 · Cited by 2
Biologic effects of 17α-dihydroequilin sulfate
Wilcox, J., Stanczyk, F. Z., Morris, R. S., Gentzschein, E., & Løbo, R. A. (1996) · Fertility and Sterility · doi:10.1016/s0015-0282(16)58629-4 · Cited by 2
Cardiovascular impact of therapy and risks
Limouzin-Lamothe, M.-A. (1984) · Springer eBooks · doi:10.1007/978-94-009-5608-7_21 · Cited by 2
Secondary Amenorrhea and the Menopause
Scommegna, A., & Carson, S. A. (1987) · Springer eBooks · doi:10.1007/978-1-4613-2157-6_17 · Cited by 2
LIU, J. H., & Arredondo, F. (2017) · Springer eBooks · doi:10.1007/978-3-319-52210-4_9 · Cited by 1
Andreeva, E. N., & Grigoryan, O. R. (2015) · Russian Journal of Human Reproduction · doi:10.17116/repro20152170-73 · Cited by 1
Effect of Estrogen on GH Secretion and Action in Postmenopausal Women
Ho, K. K. Y., & O’Sullivan, A. (1999) · Springer eBooks · doi:10.1007/978-1-4612-1546-2_6 · Cited by 1
Nelson, A. L. (2012) · Open Access Journal of Contraception · doi:10.2147/oajc.s26225 · Cited by 1
Œstrogènes, traitement hormonal, et vieillissement
Sitruk-Ware, R. L. (2015) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)30978-1 · Cited by 1
Primary and Secondary Hypogonadism in Women
Peterson, C. M., & Udoff, L. C. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-700-0_21 · Cited by 1
Hormone-induced changes in the coagulation system
Tchaikovski, S. N. (2009) · doi:10.26481/dis.20091216st · Cited by 1
Palin, S., McTernan, P. G., McGee, K. C., Sturdee, D. W., Barnett, A. H., & Kumar, S. (2007) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2006.00680.x · Cited by 1
Percutaneous oestrogen therapy
Sitruk-Ware, R. L., Basdevant, A., Lignieres, B. D., & MAUVAIS-JARVIS, P. (1984) · Springer eBooks · doi:10.1007/978-94-009-5608-7_14 · Cited by 1
Valer, V., Meléndez, R., Rivas, L., & León, I. (2013) · Anales de la Facultad de Medicina · doi:10.15381/anales.v66i1.1328 · Cited by 1
Treatment of premature ovarian failure
Cartwright, B. (2014) · Research Portal (King's College London) · Cited by 1
Hormone Replacement Therapy and Future Risks of Arterial Disease
Forbes, C. D. (1993) · Vascular Medicine Review · doi:10.1177/1358863x9300400301 · Cited by 1
Controversies in the use of hormone replacement therapy
GANGAR, K. F., Cust, M., & Whitehead, M. I. (1990) · Elsevier eBooks · doi:10.1016/b978-0-7236-0898-1.50019-8 · Cited by 1
Complications and Adverse Sequelae of Sclerotherapy
(2007) · Elsevier eBooks · doi:10.1016/b978-0-323-04258-1.50013-5 · Cited by 1
Clinical significance of the binding between oestrogens and intra- and extracellular proteins
BERGINK, E. W. (1984) · Springer eBooks · doi:10.1007/978-94-009-5608-7_7
Molecular Pharmacology of Antiresorptive Therapy for Osteoporosis
Adebanjo, O. A., Schwab, E., Sun, L., Pazianas, M., Moonga, B. S., & Zaidi, M. (1998) · Advances in organ biology · doi:10.1016/s1569-2590(08)60153-6
The Role of Hormone Replacement Therapy in the Prevention and Treatment of Osteoporosis
Ellerington, M. C., Whitehead, M. I., & Stevenson, J. C. (1994) · CPOBGYN. Clinical perspectives in obstetrics and gynecology · doi:10.1007/978-1-4612-4330-4_16
Physician-assisted suicide and euthanasia: let me count the ways.
Nickel, A. K. (1995) · Europe PMC (PubMed Central)
Lizneva, D., & Синицына, А. И. (2012) · Reproductive Endocrinology · doi:10.18370/2309-4117.2012.6.43-48
Prolactin, hormone replacement therapy, and breast cancer
Notelovitz, M. (1983) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(83)91023-2
Growth Hormone Economy in Hypogonadism: Effects of Sex Steroids
Ho, K. K. Y., Weissberger, A. J., & Kelly, J. J. (1995) · Springer eBooks · doi:10.1007/978-1-4612-2518-8_13
Predicting Predisposition to Osteoporosis: GnRH Antagonist for Acute Estrogen Deficiency
Hodgen, G. D., Kenigsberg, D., & Abbasi, R. (1987) · Springer eBooks · doi:10.1007/978-94-009-3229-6_31
Survey of Gynecological problems During Childhood and Early Adolescence in an Academic Center
Piippo, S. (2004) · Tampere University Institutional Repository (Tampere University)
Grigoryan, O. R., & Andreeva, E. N. (2015) · Russian Journal of Human Reproduction · doi:10.17116/repro201521214-17
Les pilules de 3e et 4e générations : la polémique et les nouvelles recommandations
Jandeaux, S. (2015) · HAL
Best Practice & Research Clinical Endocrinology & Metabolism
Tahboub, R., & Arafah, B. M. (2009)
Endrikat, J., Parke, S., Trummer, D., Schmidt, W., Duijkers, I. J. M., & Klipping, C. (2008)
Administration extradigestive des estrogènes: intérêt dans le traitement de la ménopause
Basdevant, A. (1988) · La Revue de Médecine Interne · doi:10.1016/s0248-8663(88)80133-4
Amrane, S., Vitez, S. F., Palmerola, K. L., & Lobo, R. A. (2020) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2020.12.010
Self-citationVenous and Arterial Risks Associated with Combined Hormonal Contraception
Reid, J. A., & Jensen, J. T. (2021) · Trends in andrology and sexual medicine · doi:10.1007/978-3-030-70932-7_9
Menopause and care of the mature woman
Lobo, R. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-65399-2.00023-1
Self-citationLIU, J. H., & Arredondo, F. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6837-0_10
DHEA, The Precursor of Androgens and Estrogens in Peripheral Tissues in the Human: Intracrinology
Labrie, F., Bélanger, A., Luu-The, V., Labrie, C., Simard, J., & Lin, S. (2011) · De Gruyter eBooks · doi:10.1515/9783110811162.299
Metadata
- Authors
- Mashchak, C. A., Lobo, R. A., Dozono-Takano, R., Eggena, P., Nakamura, R. M., Brenner, P. F., & Mishell, D. R.
- Affiliations
- University of Southern California (US)
- Corresponding author
- Mishell, Daniel R.
- Venue
- American Journal of Obstetrics and Gynecology
- Publisher
- Elsevier BV
- Published
- 1982-11
- Volume
- 144
- Issue
- 5
- Pages
- 511-518
- ISSN
- 0002-9378 (ISSN-L)
- OpenAlex
- W1593764750
- Cited by
- 316
- References
- 10
- Citations by year
- 2026: 2 · 2025: 8 · 2024: 5 · 2023: 5 · 2022: 11 · 2021: 8 · 2020: 7 · 2019: 1 · 2018: 5 · 2017: 10 · 2016: 4 · 2015: 13 · 2014: 3 · 2013: 10 · 2012: 15
- FWCI
- 2.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Obstetrics and Gynecology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Health Sciences › Nursing › Nutrition and Dietetics › Phytoestrogen effects and research
- Keywords
- pharmacodynamics, postmenopausal women, micronized estradiol, conjugated estrogens, ethinyl estradiol, diethylstilbestrol, luteinizing hormone, sex hormone-binding globulin, corticosteroid-binding globulin, angiotensinogen, estrone, estradiol, relative potency, synthetic estrogens
- MeSH terms
- Angiotensinogen, Diethylstilbestrol, Estradiol, Estrogens, Conjugated (USP), Estrogens, Estrone, Ethinyl Estradiol, Female, Follicle Stimulating Hormone, Humans, Luteinizing Hormone, Menopause, Sex Hormone-Binding Globulin, Transcortin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review